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We have tested the hypothesis that phospholipase D (PLD) is the effector of the unidentified G protein (GE) mediating Ca”-independent exocytosis 
in platelets. Although GTPyS, and to a lesser extent phorbol 12-myristate 13-acetate (PMA), caused some secretion of 5-HT from electroperme- 
abilized human platelets in the effective absence of Ca*’ (pCa > 9) these stimuli had much more potent synergistic effects when added together. 
In all cases, secretion of 5-HT was closely correlated to the stimulus-induced formation of [3H]phosphatidic a id ([‘HIPA) from [‘Hlarachidonate- 
labelled phospholipids. Addition of ethanol inhibited both secretion and [jH]PA formation and led to the accumulation of [‘Hlphosphatidylethanol 
([‘HIPEt). indicating that [‘HIPA was formed largely by activation of PLD. BAPTA and analogues caused dose-dependent inhibitions of both 
GTPyS-induced secretion and PLD activity in the permeabilized platelets. This action of BAPTA did not appear to be mediated by chelation of 
Ca” or by direct inhibition of protein kinase C (PKC). The results suggest hat PLD is the target of G, in platelets and that BAPTA can block 
PLD activation. 
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1. INTRODUCTION 
A previous study from this laboratory [l] showed that 
GTPyS can induce the Ca”-independent secretion of 
both dense and a-granule constituents from electroper- 
meabilized human platelets without causing stimulation 
of phosphoinositide-specific phospholipase C. This ac- 
tion of GTPyS was dependent on PKC activity [2] and 
was potentiated by phorbol ester (PMA) [1,2]. Similar 
studies with other permeabilized cells, particularly neu- 
trophils [3], HL-60 cells [4] and RINmSF cells [5], in 
which Ca2’-independent secretion was observed, and 
with mast cells in which Ca2* was required [6,7], have 
led Gomperts and colleagues to propose that an uniden- 
tified G protein, designated G,, may mediate GTPyS- 
induced exocytosis (reviewed in [S]). Since treatment of 
rabbit platelets with PMA enhances the ability of 
GTPyS to stimulate PLD in membrane preparations 
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[9], we have suggested that PLD may be the effector of 
G, in platelets [l]. In the present study, we have investi- 
gated this possibility and have demonstrated a close 
correlation between the Ca2’-independent release of a 
dense granule constituent (5HT) and activation of PLD 
in permeabilized human platelets incubated with 
GTPyS and/or PMA. 
There is evidence that the Ca2’-chelator BAPTA [lo] 
can inhibit GTPyS-induced secretion from a number of 
cell types by a mechanism that may be unrelated to its 
ability to bind Ca” ions [l 11. Thus in electropermeabil- 
ized platelets, the secretion of both dense granule and 
lysosomal constituents in response to GTPyS was abol- 
ished by 20 mM BAPTA but not by 20 mM EGTA. 
although the equilibrium affinities of these compounds 
for Ca2’ were similar under the conditions of these ex- 
periments [12]. In permeabilized neutrophils, much less 
GTPyS-induced secretion of /?-glucuronidase was seen 
in the presence of BAPTA than of EGTA [3]. Finally, 
dibromo-BAPTA (4 mM) inhibited GTPyS-induced ex- 
ocytosis from mast cells, despite the presence of Ca”’ 
[13]. Since these actions of BAPTA have not been ade- 
quately explained, we investigated the effects of BAPTA 
and analogues on both the Ca2+-independent secretion 
of 5-HT from permeabilized platelets and the associated 
activation of PLD. The results provide further evidence 
of a role for PLD in secretion. 
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2. EXPERIMENTAL 
2.1. Materials 
[5,6,8,9,11,12,14,15-3H]Arachidonic acid (100 Ci/mmol) and [r- 
‘*P]ATP (3000 Wmmol) were obtained from Du Pont, Mississauga, 
ON, Canada, and [side-chain-2-‘4C]5-HT (55 mWmmo1) from Amer- 
sham, Oakville, ON, Canada. GTPyS was from Boehringer 
Mannheim, Laval, PQ, Canada, and PMA and BAPTA from Sigma, 
St. Louis, MO, USA. BAPTA was also obtained from Fluka, Ron- 
konkoma, NY, USA. 5,5’-Dibromo-BAPTA was from Molecular 
Probes, Eugene, OR, USA and 5,5’-dinitro-BAPTA was a generous 
gift from Dr. M.P. Charlton, Department of Physiology, University 
of Toronto, Toronto, ON, Canada. Other materials were from sources 
listed previously [1,14]. 
2.2. Label&g and electropermeabilization of platelets 
Human platelets, isolated as described previously [14], were resus- 
pended at 5 x 109/ml in titrated plasma, pH 6.5, and incubated at 37°C 
for 1.5 h with [3H]arachidonate (5@/ml). [14C]5-HT was added in 
three equal amounts during the last 30 min (to a final concentration 
of 0.25 &i/ml). The platelets were then washed in Ca*‘-free Tyrode’s 
solution containing 5 mM PIPES (pH 6.5) and 0.35% (w/v) bovine 
serum albumin and, after addition of 5 mM EGTA, were permeabil- 
ized by high-voltage lectric discharges [14]. The permeabilized plate- 
lets were cooled to 4”C, freed from low-M, solutes by gel filtration [14] 
and eluted in a medium (pH 7.4) containing 3.9 mM MgCl, and the 
potassium salts of glutamic acid (160 mM), HEPES (20 mM), EDTA 
(2.5 mM) and EGTA (2.5 mM). ATP (final concentration 5 mM) was 
added to the eluate, which was adjusted to contain 5 x 10’ platelets/ml. 
This suspension was stored at O’C until used (30-60 min). 
2.3. Incubations 
All samples of permeabilized platelet suspension were first equili- 
brated for 15 min at 0°C with an additional 10 mM EGTA (to give 
a pCa > 9 even after release of platelet Ca’+ [l]), with sufficient MgCl, 
to give 5.0 mM Mgz’r,,. and with any other additions. Concentrations 
of added MgCl, were calculated using binding constants given else- 
where [10,15]. After equilibration, samples (final vol. 0.4 ml containing 
1.6 x lOa platelets) were incubated for 10 min at 25°C before measure- 
ment of [‘4C]5-HT secretion in 0.05 ml portions [14] and extraction of 
lipids from the remainder [16]. [‘HIPA and [-‘HIPEt were then isolated 
by t.1.c. [17] and counted for ‘H as in [9]. Basal values for extracellular 
[?Z]S-HT and for “H-labelled lipids were obtained from permeahilized 
platelet suspension stored at 0°C and subtracted from values obtained 
after incubations. These corrections were very small for [14C]5-HT and 
[‘HIPEt, but significant [3H]PA was present prior to incubations. To 
normalize results from different experiments, ‘H-labelled lipids were 
expressed as percentages of total platelet ‘H. In some experiments, 
PKC activation was measured in small samples of permeabilized plate- 
let suspension (0.1 ml) containing [T-~~P]ATP (16 PCi) by determining 
the phosphorylation of its major substrate, pleckstrin [1,14]. 
3. RESULTS 
3.1. Relationship between secretion and J3H]PA forma- 
tion 
In the absence of additions, incubation of permeabil- 
ized platelets at a pCa > 9 did not lead to [14C]5-HT 
secretion, though some [3H]PA was formed (Fig. 1). 
However, equilibration of the platelets with 100 PM 
GTPyS, or even with 100 nM PMA, caused significant 
secretion of [14C]5-HT at pCa > 9 and enhanced [3H]PA 
formation. Moreover, when added together, these stim- 
uli induced a much more marked secretion that was on 
average 2.2-fold greater than the sum of their individual 
effects (Fig. 1A). In these experiments, the effect of 
60 03 5 
0 00 
Control GTPyS PMA 
PMA 
Control GTPyS PMA 
PMA 
GT&S GT&S 
Fig. 1. Effects of GTPyS and PMA on Ca”-independent 5-HT secre- 
tion and PA formation in permeabilized platelets. Samples of labelled 
permeabilized platelets were incubated with no stimulus (control), 100 
PM GTPyS, 100 nM PMA or 1OOpM GTPyS and 100 nM PMA, as 
indicated. Secretion of [“‘Cl5-HT (A) and the increases in [‘HIPA (B) 
were determined. To normalize results from different experiments, 
[3H]PA was expressed as a percentage of the total ‘H in the permeabil- 
ized platelets; basal [3H]PA (0.071 + 0.004% of platelet ‘H) was sub- 
tracted. Values shown are means f S.E. from all experiments (n = 17); 
the significance of changes was evaluated by two-sided paired t-tests 
(*P < 0.001). 
PMA alone was weaker and the synergism between 
GTPyS and PMA stronger than in a previous study at 
pCa > 9 [l] in which the [M$r,,] was 2.7 mM, rather 
than 5.0 mM. Measurement of [3H]PA accumulation in 
the same experimental samples (Fig. IB) showed that 
the stimulus-induced formation of this phospholipid 
closely paralleled secretion. In particular, the increases 
in [3H]PA caused by simultaneous addition of GTPyS 
and PMA amounted to 2.4-fold the sum of the increases 
they induced individually. 
3.2. Role of PLD activity in [‘HIPA formation 
Since phosphoinositide-specific phospholipase C ac- 
tivity was not detected in permeabilized platelets incu- 
bated at pCa > 9 [l], the role of PLD in [3H]PA forma- 
tion was evaluated. The decreases in the amounts of 
[3H]PA formed on addition of ethanol and the associ- 
ated accumulation of [3H]PEt by transphosphatidyla- 
tion were used as measures of PLD activity [17]. Addi- 
tion of 400 mM ethanol markedly inhibited the accumu- 
lation of [3H]PA caused by GTPyS alone or by GTPyS 
and PMA (Fig. 2A); in three separate xperiments, these 
inhibitions amounted to 64 + 7% and 74 f 7%, respec- 
tively (mean values * S.E.). These actions of ethanol 
were associated with the formation of amounts of 
[3H]PEt comparable to or larger than the decreases in 
[3H]PA (Fig. 2B). When present together, GTPyS and 
PMA had markedly supra-additive effects on [3H]PEt 
formation (Fig. 2B), showing that these stimuli acted 
synergistically to increase PLD activity. Although etha- 
nol had little effect on [3H]PA accumulation in platelets 
incubated with PMA alone, [3H]PEt formation was al- 
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Fig. 2. Effects of ethanol on Cal’-independent PA and PEt formation 
and on the associated 5-HT secretion. Samples of labelled permeabil- 
ized platelets were incubated with no stimulus (control), 100 PM 
GTPJS, 100 nM PMA or 100 PM GTPyS and 100 nM PMA, in each 
case in the absence (W and presence (m) of 400 mM ethanol. The 
formation of both [‘HIPA (A) and [‘HIPEt (B) and the secretion of 
[‘%Z]5-HT (C) were determined. Values are means f SE. from triph- 
cate incubations in a single experiment; significant effects of ethanol 
(two-sided unpaired r-test) are shown: *P < 0.05; **P < 0.01 
ways observed. However, in control incubations with 
ethanol, little or no [3H]PEt was detected and ethanol 
tended to increase rather than decrease [3H]PA accumu- 
lation, though this was rarely significant in individual 
experiments (Fig. 2A). These results indicate that stimu- 
lus-induced [3H]PA formation is largely attributable to 
PLD activity, whereas in control incubations, [3H]PA 
appears to be formed by other mechanisms. 
Ethanol (400 mM) markedly inhibited [‘4C]5-HT se- 
cretion induced by GTPyS or by GTPyS and PMA 
(Fig. 2C); these inhibitions amounted to 74 + 3% and 
47 ? 3%, respectively (means + SE.; 3 experiments). 
However, ethanol had no significant effect on the weak 
secretion caused by PMA alone (Fig. 2C). This observa- 
tion may, in part, be explained by a small increase in 
[14C]5-HT secretion caused by ethanol in control sam- 
ples. As a whole, these results demonstrate acorrelation 
between the effects of ethanol on the accumulation of 
[3H]PA attributable to PLD activation and its effect on 
[14C]5-HT secretion. The residual secretion observed in 
the presence of ethanol correlated with both the residual 
stimulus-induced [3H]PA accumulation and with 
[3H]PEt formation. 
3.3. Inhibition of .5-HT secretion and PLD activation by 
BA PTA and analogues 
High (mM) concentrations of BAPTA have been re- 
ported to inhibit Ca”‘-independent secretion from per- 
meabilized cells, including platelets [11,121. The results 
in Table I confirm this and show that BAPTA also 
inhibited the increases in [3H]PA caused by GTPyS and/ 
or PMA. To study the relationship between the effects 
of BAPTA on secretion and PLD activity, [3H]PEt for- 
mation was measured in the presence of 200 mM etha- 
nol, which inhibited the secretion of [14C]5-HT induced 
by GTPyS alone and by GTPyS with PMA by only 
34 ? 4% and 15 ?- 2%, respectively (mean values + S.E., 
5 experiments). Under these conditions, the IC,, for 
inhibition of the GTPyS-induced secretion of [14C]5-HT 
Table I 
Effects of BAPTA on Ca”-Independent 5-HT secretion, PA formation and pleckstrin phosphorylation in permeabilized platelets 
Additions Secretion of 10-j x Increase in [3H]PA “P in pleckstrin 
[“‘Cl5-HT (8%) (d.p.m./lO’ platelets) (pmol/109 platelets) 
BAPTA + BAPTA - BAPTA + BAPTA - BAPTA + BAPTA 
None 3fl 420 3.3 * 0.4 2.9 f. 0.4 101 f 8 73? 6 
GTPyS 26f 1 7f 1** 5.7 f 0.3 3.6 f O.l** 219 f 8 ill? 2** 
PMA 12f 1 8f 1* 5.2 f 0.5 3.8 f 0.1* 329 f 3 320 f 25 
GTPyS + PMA 51 + 3 25 f l** 12.3 + 0.8 7.6 + OS* 319 + 9 326 + 7 
Samples of labelled permeabilized platelets were incubated with no stimulus, 100,uM GTP#, 100 nM PMA or IOOpM GTPyS and 100 nM PMA. 
in each case in the absence and presence of 10 mM BAPTA. The secretion of [“‘Cl5-HT and formation of [3H]PA were determined from triplicate 
incubations in the same experiment. [y-‘2P]ATP was added to addttional duplicate samples for measurement of pleckstrin phosphorylation. Values 
are means f SE.; the significance of the effects of BAPTA was evaluated by two-sided unpaired t-tests (*P < 0.05; **P < 0.01). 
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Fig. 3. Inhibition of Ca”-independent 5-HT secretion and PEt forma- 
tion by BAPTA. Samples of labelled permeabilized platelets were 
incubated with the indicated concentrations of BAPTA and either 100 
PM GTPyS (0, q ) or 100pM GTPyS and 100 nM PMA (0, n ), in each 
case in the presence of 200 mM ethanol. Secretion of [14C]5-HT (0, l ) 
and the formation of [‘HIPEt (0, n ) were determined. Values are 
means f S.E. from triplicate incubations in the same experiment. 
by BAPTA was less than 2 mM, whereas the ICso for 
inhibition of the synergistic effect of GTPyS and PMA 
was about 5 mM (Fig. 3). The results also show that 
BAPTA caused parallel dose-dependent inhibitions of 
PLD activation ([3H]PEt formation). In five separate 
experiments, 10 mM BAPTA inhibited GTPyS-induced 
secretion and [3H]PEt formation by 71 + 3% and 
64 * 5%, respectively, whereas the corresponding ef- 
fects of GTPyS with PMA were inhibited by 66 + 3% 
and 52 * 3%, respectively (mean values f S.E.). 
Dibromo-BAPTA was considerably more effective than 
BAPTA as an inhibitor of both the Ca2’-independent 
[14C]5-HT secretion and [3H]PEt formation induced by 
GTPyS with PMA; 1 mM dibromo-BAPTA and 4 mM 
BAPTA were roughly equipotent (Table II). Dinitro- 
BAPTA had effects on secretion and PLD activity inter- 
mediate between those of BAPTA and dibromo- 
BAPTA (not shown). 
To investigate the mechanism of action of BAPTA, 
the phosphorylation of pleckstrin during Ca2’-inde- 
pendent secretion from permeabilized platelets was also 
studied (Table I). BAPTA (10 mM) did not affect the 
phosphorylation of this protein induced by PMA added 
with or without GTPyS, indicating that BAPTA did not 
directly inhibit PKC. However, BAPTA did inhibit the 
phosphorylation of pleckstrin caused by GTPyS alone, 
suggesting that PA formed by PLD, or a PA metabolite, 
may activate PKC. 
4. DISCUSSION 
The results provide three independent lines of evi- 
dence consistent with the hypothesis [l] that the target 
of GE in the platelet is PLD. First, GTPyS and PMA 
acted synergistically in permeabilized platelets to stimu- 
late both Ca”-independent secretion of 5-HT and PLD 
activity, whether the latter was measured as the accu- 
mulation of [3H]PA in the absence of ethanol or of 
[3H]PEt in the presence of ethanol. This synergistic acti- 
vation of PLD is in accord with a previous report in 
which rabbit platelet membranes were studied [9], as 
well as with recent work on permeabilized HL-60 cells 
[18]. Second, ethanol inhibited the GTPyS-induced se- 
cretion of 5-HT from permeabilized platelets and 
caused comparable decreases in [3H]PA accumulation, 
which were attributable to the formation of [3H]PEt by 
PLD-catalysed transphosphatidylation. Similar effects 
of ethanol on stimulus-induced PA accumulation and 
secretion in intact mast cells [19] and differentiated HL- 
60 cells [20] have been cited as evidence of a role for 
PLD in these cells. Third, BAPTA and analogues 
caused parallel concentration-dependent i hibitions of 
GTPyS-induced secretion and PLD activity in permea- 
bilized platelets, despite the presence of sufficient 
EGTA to give a pCa > 9. This unexpected result not 
only greatly strengthens the correlation between secre- 
tion and PLD activity, but can also explain previously 
reported anomalous inhibitory effects of BAPTA and 
analogues on secretion from permeabilized platelets [121 
and other cells [3,11,13]. It is of interest that dibromo- 
BAPTA, which has an equilibrium affinity for Ca2’ 
about tenfold lower than that of BAPTA [10,21], was 
about fourfold more potent than BAPTA as an inhibi- 
Table II 
Comparison of the inhibitory effects of dibromo-BAPTA and BAPTA 
on Ca”-independent secretion and PLD activity in permeabilized 
platelets 
Inhibitor Secretion of lo-’ x Increase in 
[“‘Cl5-HT (I) rH]PEt (d.p.m./ 
IO9 platelets) 
None 
Dibromo-BAPTA (1 mM) 
Dibromo-BAPTA (4 mM) 
BAPTA (4 mM) 
41+2 9.6 f 0.4 
27f 1* 7.9 + 0.7 
8f I* 3.2 f O.l* 
23% I* 7.4 +_ 0.2+ 
Samples of labelled permeabilized platelets were incubated with 100 
PM GTPyS and 100 nM PMA in the presence of 200 mM ethanol and 
the indicated concentrations of dibromo-BAPTA or BAPTA. The 
secretion of [‘4C]5-HT and formation of [‘HIPEt were determined 
from triplicate incubations in the same experiment; values are means 
f S.E. The significance of changes was evaluated by two-sided un- 
paired r-tests (*P < 0.05). 
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tor of secretion and PLD activity. Although BAPTA 
binds Ca2+ more rapidly than does EGTA [lo], which 
may account for the ability of the former to block neu- 
rotransmitter elease [22], differences in the Ca”-bind- 
ing kinetics of these chelating agents are unlikely to 
explain the present results. Thus, we have observed sim- 
ilar inhibitions of GTPyS-stimulated secretion and 
PLD activity by BAPTA in the presence of Ca2’ buff- 
ered to a final pCa of 6 [2]. Moreover, dinitro-BAPTA, 
which has little or no Ca*‘-binding capacity [21], was 
slightly more potent than BAPTA as an inhibitor of 
secretion and PLD activity in our experiments. We con- 
clude that BAPTA and analogues do not inhibit secre- 
tion by chelation of Ca*‘. In addition, BAPTA did not 
appear to exert a direct inhibitory effect on PKC in 
permeabilized platelets and may therefore act on either 
GE or PLD itself. 
Although our results are most simply explained if 
activation of PLD by a hypothetical G, mediates the 
stimulation of secretion by GTPyS, more complex 
mechanisms involving multiple GTP-binding proteins 
and target enzymes cannot easily be excluded, particu- 
larly in intact cells. However, the absence of significant 
GTPyS-induced inositol phosphate or diacylglycerol 
formation in permeabilized platelets at pCa > 9 [ 1.21 
indicates that phospholipase C activity has no role in 
secretion under the conditions of the present study. 
Moreover, although preliminary work shows that 
GTPyS and PMA act synergistically to stimulate phos- 
pholipase A, at pCa > 9, inhibition of this enzyme did 
not affect secretion from permeabilized platelets 
(Coorssen, Davidson and Haslam, in preparation). 
These considerations focus attention on the possibility 
that PA generated by PLD acts as a second messenger 
that mediates ecretion from platelets. A similar role for 
PLD has also been suggested by others working with 
mast cells [19], HL-60 cells [20] and pancreatic islets 
[23]. However, in intact human platelets, PLD activity 
accounts for only l&20% of the total PA that accumu- 
lates after stimulation by thrombin [2,24]; most of the 
PA is formed by the sequential actions of phospholipase 
C and diacylglycerol kinase. Thus, a major role for PLD 
in secretion from intact platelets is only likely if the PA 
generated by this enzyme differs in its fatty acid compo- 
sition or, more plausibly, in its subcellular localization 
from that formed as a result of phospholipase C activ- 
ity. Some support for this possibility is provided by our 
observation that the PA accumulating in control incu- 
bations of permeabilized platelets was formed by a 
PLD-independent mechanism and was not associated 
with secretion. There are multiple mechanisms through 
which PA generated by PLD might enhance secretion. 
These include activation of PKC, as suggested by the 
GTPyS-induced phosphorylation of pleckstrin [l], stim- 
ulation of other protein kinases [25], effects on factors 
that regulate low-M, GTP-binding proteins [26] and a 
direct membrane-fusogenic a tion [27]. 
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